Reply from Pomerantz Law:
Apparently you didn’t read what I wrote.
Sent from my iPhone
On Nov 16, 2018, at 11:42 AM, Robert Willoughby <rswilloughby@pomlaw.com> wrote:
Dear Mr. Naccarato,
Thank you for contacting us regarding Amarin Corporation.
We would like to file a complaint on your behalf.
There is no cost to you or any shareholder to join or participate in the class action.
The next step would entail you sending us copies of all your trade confirmations detailing your purchases and or sale of the shares and completing the attached certification form to join in on the class action filing.
Please confirm that you have not provided this information to another law firm regarding this case and that you have not sought to be a lead plaintiff in another case within the past 3 years?
For more information on our company, you may visit our website at www.pomlaw.com.
Best regards,
Robert Willoughby
Investor Relations Manager
POMERANTZ LLP
600 Third Avenue, 20th Floor
New York, NY 10016
Tel. 212.661.1100, ext. 9980
Fax 646-355-0083
www.pomlaw.com
rswilloughby@pomlaw.com
-----Original Message-----
From: Mike Naccarato <naccarato.mike@gmail.com>
Sent: Wednesday, November 14, 2018 3:20 PM
To: Robert Willoughby <rswilloughby@pomlaw.com>
Subject: Amarin
Your firm should be ashamed. You actually have the guts to investigate a class action lawsuit against Amarin? Thanks to your notification yesterday the stock dropped 20% on this BS. You actually have the guts to quote a SeekingAlpha article? That is a complete joke. I have been a long-term shareholder of Amarin and I am appalled by your firm’s behavior. I firmly believe in the science and so do 90% of cardiologist after the REDUCE-IT study was announced. Learn your facts before you do something ridiculous like this ever again.
Sent from my iPhone
This email and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this email, you are hereby notified any dissemination, distribution or copying of this email, and any attachments thereto, is strictly prohibited. If you receive this email in error please immediately notify me at (212) 661-1100 and permanently delete all copies of the email and any attachments.
<Amarin Shareholder Certification (00301731xC40C2).pdf>
<Amarin Complaint (00301554xC40C2).docx>
